Literature DB >> 10656355

Excessive use of vancomycin: a successful intervention strategy at an academic medical center.

C D Hamilton1, R Drew, S W Janning, J K Latour, S Hayward.   

Abstract

The project goal was to decrease excessive vancomycin use. Interventions included an educational chart note the first day of therapy, followed by pharmacists discussing the need for continued therapy with patients' physicians. Empirical vancomycin use improved from 20% to 90% compliance with guidelines within 6 months of the intervention.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10656355     DOI： 10.1086/501703

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  9 in total

Review 1.  Antimicrobial stewardship programs in health care systems.

Authors:  Conan MacDougall; Ron E Polk
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

2.  Inappropriate continued empirical vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus.

Authors:  Nak-Hyun Kim; Hei Lim Koo; Pyoeng Gyun Choe; Pyeong Gyun Choe; Shinhye Cheon; Moonsuk Kim; Moon Suk Kim; Myung Jin Lee; Younghee Jung; Young Hee Jung; Wan Beom Park; Kyoung-Ho Song; Eu Suk Kim; Ji Hwan Bang; Hong Bin Kim; Sang Won Park; Nam Joong Kim; Myoung-don Oh; Eui Chong Kim
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

3.  Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infections.

Authors:  C R Kumana; T Y Ching; Y Kong; E C Ma; M Kou; R A Lee; V C Cheng; S S Chiu; W H Seto
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 4.  Glycopeptide antibiotics: from conventional molecules to new derivatives.

Authors:  Françoise Van Bambeke; Yves Van Laethem; Patrice Courvalin; Paul M Tulkens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital.

Authors:  V C C Cheng; K K W To; I W S Li; B S F Tang; J F W Chan; S Kwan; R Mak; J Tai; P Ching; P L Ho; W H Seto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-01       Impact factor: 3.267

6.  Vancomycin and home health care.

Authors:  Thomas G Fraser; Valentina Stosor; Qiong Wang; Anne Allen; Teresa R Zembower
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

7.  Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study.

Authors:  Moacyr S Junior; Luci Correa; Alexandre R Marra; Luis F A Camargo; Carlos A P Pereira
Journal:  BMC Infect Dis       Date:  2007-08-01       Impact factor: 3.090

8.  Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasi-experimental study in a region of high MRSA prevalence.

Authors:  Pyoeng Gyun Choe; Hei Lim Koo; Doran Yoon; Ji Yun Bae; Eunyoung Lee; Joo-Hee Hwang; Kyoung-Ho Song; Wan Beom Park; Ji Hwan Bang; Eu Suk Kim; Hong Bin Kim; Sang Won Park; Myoung-Don Oh; Nam Joong Kim
Journal:  BMC Infect Dis       Date:  2018-04-16       Impact factor: 3.090

9.  Effects of Pharmacist Intervention on the Utilization of Vancomycin in a Teaching Hospital.

Authors:  Maria Tavakoli-Ardakani; Samaneh Ghassemi; Afshin Mohammad Alizadeh; Jamshid Salamzadeh; Mojtaba Ghadiani; Sara Ghassemi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.